News

Statins reduce cardiovascular risk

BMJ 2002; 325 doi: 10.1136/bmj.325.7354.5/a (Published 6 July 2002)
Cite this as: BMJ 2002;325:5.2

    More topics

  • Stroke

    • Fewer topics

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Susan Mayor
  1. London

    Treating patients at high risk of cardiovascular events with the HMG-CoA (hydroxymethyl glutaryl coenzyme A) reductase inhibitor simvastatin reduced the risk of myocardial infarction, stroke, and revascularisation by about one third, even in patients with normal or low blood cholesterol levels, according to the latest findings from the heart protection study published this week.

    The study randomised 20536 adults with coronary disease, other occlusive artery disease, or diabetes to treatment with simvastatin (40 …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular